Home » Authors » Trista Morrison

Trista Morrison

Articles

ARTICLES

Cannasat and IntelGenx Expand Cannabinoid-Based Collaboration

March 21, 2007

By Trista Morrison

Cannasat and IntelGenx Expand Cannabinoid-Based Collaboration

March 21, 2007

By Trista Morrison

Cleveland BioLabs Raises $30M, Pursues DOD Contract

March 20, 2007

By Trista Morrison

Intarcia Is Re-Born With $50M Series BB Financing

March 20, 2007

By Trista Morrison

Intarcia Is Re-Born With $50M Series BB Financing

March 20, 2007

By Trista Morrison

Cleveland BioLabs Raises $30M, Pursues DOD Contract

March 20, 2007

By Trista Morrison

Pfizer, Biogen Idec Launch Incubators To Build Pipelines

March 19, 2007

By Trista Morrison

Tracon Licenses D93 Antibody From Micromet

March 19, 2007

By Trista Morrison

In a deal worth up to $100 million, Micromet Inc. licensed the preclinical anti-angiogenesis monoclonal antibody D93 to privately held Tracon Pharmaceuticals Inc. (BioWorld Today)

Tracon Licenses D93 Antibody From Micromet

March 19, 2007

By Trista Morrison

In a deal worth up to $100 million, Micromet Inc. licensed the preclinical anti-angiogenesis monoclonal antibody D93 to privately held Tracon Pharmaceuticals Inc. (BioWorld Today)

Pfizer, Biogen Idec Launch Incubators To Build Pipelines

March 19, 2007

By Trista Morrison

View All Articles by Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...